β2-AR signaling controls trastuzumab resistance-dependent pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

β2-AR signaling controls trastuzumab resistance-dependent pathway

Published:2015-03-23 Issue:1 Volume:35 Page:47-58
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Liu D,Yang Z,Wang T,Yang Z,Chen H,Hu Y,Hu C,Guo L,Deng Q,Liu Y,Yu M,Shi M,Du N,Guo N

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc201558.pdf

Reference63 articles.

1. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353: 1673–1684.

2. Seidman AD, Berry D, Cirrincione C, Harris L, Muss H, Marcom PK et al. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840. J Clin Oncol 2008; 26: 1642–1649.

3. Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L . Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol 2012; 9: 16–32.

4. Stern HM . Improving treatment of HER2-positive cancers: opportunities and challenges. Sci Transl Med 2012; 4: 127rv122.

5. Mukohara T . Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer. Cancer Sci 2011; 102: 1–8.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. pH-responsive coacervate with adrenergic nerve blockade function inhibits triple-negative breast cancer metastasis by blocking nerve-tumor-immune loop;Chemical Engineering Journal;2024-08

2. Nerve-tumor crosstalk in tumor microenvironment: From tumor initiation and progression to clinical implications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

3. Harnessing adrenergic blockade in stress-promoted TNBC in vitro and solid tumor in vivo: disrupting HIF-1α and GSK-3β/β-catenin driven resistance to doxorubicin;Frontiers in Pharmacology;2024-06-19

4. Biological mechanisms of resistance to trastuzumab and ways to overcome them: Mod-ern problems of clinical oncology;Regulatory Mechanisms in Biosystems;2024-05-11

5. Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer;Current Issues in Molecular Biology;2024-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3